624: Harzstark AL, Small EJ. Castrate-resistant prostate cancer: therapeutic strategies. Expert Opin Pharmacother. 2010 Apr;11(6):937-45. doi: 10.1517/14656561003677382. Review. PubMed PMID: 20307219. 625: Harzstark AL, Small EJ. Immunotherapeutics in development for prostate cancer. Oncologist. 2009 Apr;14(4):391-8. doi: 10.1634/theoncologist.2008-0240. Epub 2009 Apr 2. Review. PubMed PMID: 19342474. 626: Harzstark AL, Ryan CJ. Therapies in development for castrate-resistant prostate cancer. Expert Rev Anticancer Ther. 2008 Feb;8(2):259-68. doi: 10.1586/14737140.8.2.259. Review. PubMed PMID: 18279066. 627: Harzstark AL, Small EJ. Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge). Expert Opin Biol Ther. 2007 Aug;7(8):1275-80. Review. PubMed PMID: 17696825.